Global Genomics In Cancer Care Market 2022 by Company, Regions, Type and Application, Forecast to 2028

Global Genomics In Cancer Care Market 2022 by Company, Regions, Type and Application, Forecast to 2028

Table of Contents

1 Market Overview
1.1 Product Overview and Scope of Genomics In Cancer Care
1.2 Classification of Genomics In Cancer Care by Type
1.2.1 Overview: Global Genomics In Cancer Care Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Genomics In Cancer Care Revenue Market Share by Type in 2021
1.2.3 Instruments
1.2.4 Consumables
1.2.5 Services
1.3 Global Genomics In Cancer Care Market by Application
1.3.1 Overview: Global Genomics In Cancer Care Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Diagnostics
1.3.3 Personalized Medicine
1.3.4 Drug Discovery
1.3.5 Development
1.3.6 Research
1.4 Global Genomics In Cancer Care Market Size & Forecast
1.5 Global Genomics In Cancer Care Market Size and Forecast by Region
1.5.1 Global Genomics In Cancer Care Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Genomics In Cancer Care Market Size by Region, (2017-2022)
1.5.3 North America Genomics In Cancer Care Market Size and Prospect (2017-2028)
1.5.4 Europe Genomics In Cancer Care Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Genomics In Cancer Care Market Size and Prospect (2017-2028)
1.5.6 South America Genomics In Cancer Care Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Genomics In Cancer Care Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Genomics In Cancer Care Market Drivers
1.6.2 Genomics In Cancer Care Market Restraints
1.6.3 Genomics In Cancer Care Trends Analysis
2 Company Profiles
2.1 Illumina
2.1.1 Illumina Details
2.1.2 Illumina Major Business
2.1.3 Illumina Genomics In Cancer Care Product and Solutions
2.1.4 Illumina Genomics In Cancer Care Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 Illumina Recent Developments and Future Plans
2.2 Thermo Fisher scientific
2.2.1 Thermo Fisher scientific Details
2.2.2 Thermo Fisher scientific Major Business
2.2.3 Thermo Fisher scientific Genomics In Cancer Care Product and Solutions
2.2.4 Thermo Fisher scientific Genomics In Cancer Care Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 Thermo Fisher scientific Recent Developments and Future Plans
2.3 Agilent
2.3.1 Agilent Details
2.3.2 Agilent Major Business
2.3.3 Agilent Genomics In Cancer Care Product and Solutions
2.3.4 Agilent Genomics In Cancer Care Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 Agilent Recent Developments and Future Plans
2.4 Roche
2.4.1 Roche Details
2.4.2 Roche Major Business
2.4.3 Roche Genomics In Cancer Care Product and Solutions
2.4.4 Roche Genomics In Cancer Care Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 Roche Recent Developments and Future Plans
2.5 Cancer Genetics
2.5.1 Cancer Genetics Details
2.5.2 Cancer Genetics Major Business
2.5.3 Cancer Genetics Genomics In Cancer Care Product and Solutions
2.5.4 Cancer Genetics Genomics In Cancer Care Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 Cancer Genetics Recent Developments and Future Plans
2.6 Beckman Coulter
2.6.1 Beckman Coulter Details
2.6.2 Beckman Coulter Major Business
2.6.3 Beckman Coulter Genomics In Cancer Care Product and Solutions
2.6.4 Beckman Coulter Genomics In Cancer Care Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 Beckman Coulter Recent Developments and Future Plans
2.7 Bio-Rad
2.7.1 Bio-Rad Details
2.7.2 Bio-Rad Major Business
2.7.3 Bio-Rad Genomics In Cancer Care Product and Solutions
2.7.4 Bio-Rad Genomics In Cancer Care Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 Bio-Rad Recent Developments and Future Plans
2.8 Danaher
2.8.1 Danaher Details
2.8.2 Danaher Major Business
2.8.3 Danaher Genomics In Cancer Care Product and Solutions
2.8.4 Danaher Genomics In Cancer Care Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 Danaher Recent Developments and Future Plans
2.9 Sigma Aldrich
2.9.1 Sigma Aldrich Details
2.9.2 Sigma Aldrich Major Business
2.9.3 Sigma Aldrich Genomics In Cancer Care Product and Solutions
2.9.4 Sigma Aldrich Genomics In Cancer Care Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 Sigma Aldrich Recent Developments and Future Plans
2.10 Pacific Biosciences
2.10.1 Pacific Biosciences Details
2.10.2 Pacific Biosciences Major Business
2.10.3 Pacific Biosciences Genomics In Cancer Care Product and Solutions
2.10.4 Pacific Biosciences Genomics In Cancer Care Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10.5 Pacific Biosciences Recent Developments and Future Plans
2.11 Quest Diagnostics
2.11.1 Quest Diagnostics Details
2.11.2 Quest Diagnostics Major Business
2.11.3 Quest Diagnostics Genomics In Cancer Care Product and Solutions
2.11.4 Quest Diagnostics Genomics In Cancer Care Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11.5 Quest Diagnostics Recent Developments and Future Plans
2.12 Luminex
2.12.1 Luminex Details
2.12.2 Luminex Major Business
2.12.3 Luminex Genomics In Cancer Care Product and Solutions
2.12.4 Luminex Genomics In Cancer Care Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12.5 Luminex Recent Developments and Future Plans
2.13 Oxford Gene Technology
2.13.1 Oxford Gene Technology Details
2.13.2 Oxford Gene Technology Major Business
2.13.3 Oxford Gene Technology Genomics In Cancer Care Product and Solutions
2.13.4 Oxford Gene Technology Genomics In Cancer Care Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13.5 Oxford Gene Technology Recent Developments and Future Plans
2.14 PerkinElmer
2.14.1 PerkinElmer Details
2.14.2 PerkinElmer Major Business
2.14.3 PerkinElmer Genomics In Cancer Care Product and Solutions
2.14.4 PerkinElmer Genomics In Cancer Care Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14.5 PerkinElmer Recent Developments and Future Plans
2.15 Qiagen
2.15.1 Qiagen Details
2.15.2 Qiagen Major Business
2.15.3 Qiagen Genomics In Cancer Care Product and Solutions
2.15.4 Qiagen Genomics In Cancer Care Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15.5 Qiagen Recent Developments and Future Plans
2.16 GE Healthcare
2.16.1 GE Healthcare Details
2.16.2 GE Healthcare Major Business
2.16.3 GE Healthcare Genomics In Cancer Care Product and Solutions
2.16.4 GE Healthcare Genomics In Cancer Care Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.16.5 GE Healthcare Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Genomics In Cancer Care Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Genomics In Cancer Care Players Market Share in 2021
3.2.2 Top 10 Genomics In Cancer Care Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Genomics In Cancer Care Players Head Office, Products and Services Provided
3.4 Genomics In Cancer Care Mergers & Acquisitions
3.5 Genomics In Cancer Care New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Genomics In Cancer Care Revenue and Market Share by Type (2017-2022)
4.2 Global Genomics In Cancer Care Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
5.1 Global Genomics In Cancer Care Revenue Market Share by Application (2017-2022)
5.2 Global Genomics In Cancer Care Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
6.1 North America Genomics In Cancer Care Revenue by Type (2017-2028)
6.2 North America Genomics In Cancer Care Revenue by Application (2017-2028)
6.3 North America Genomics In Cancer Care Market Size by Country
6.3.1 North America Genomics In Cancer Care Revenue by Country (2017-2028)
6.3.2 United States Genomics In Cancer Care Market Size and Forecast (2017-2028)
6.3.3 Canada Genomics In Cancer Care Market Size and Forecast (2017-2028)
6.3.4 Mexico Genomics In Cancer Care Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
7.1 Europe Genomics In Cancer Care Revenue by Type (2017-2028)
7.2 Europe Genomics In Cancer Care Revenue by Application (2017-2028)
7.3 Europe Genomics In Cancer Care Market Size by Country
7.3.1 Europe Genomics In Cancer Care Revenue by Country (2017-2028)
7.3.2 Germany Genomics In Cancer Care Market Size and Forecast (2017-2028)
7.3.3 France Genomics In Cancer Care Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Genomics In Cancer Care Market Size and Forecast (2017-2028)
7.3.5 Russia Genomics In Cancer Care Market Size and Forecast (2017-2028)
7.3.6 Italy Genomics In Cancer Care Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Genomics In Cancer Care Revenue by Type (2017-2028)
8.2 Asia-Pacific Genomics In Cancer Care Revenue by Application (2017-2028)
8.3 Asia-Pacific Genomics In Cancer Care Market Size by Region
8.3.1 Asia-Pacific Genomics In Cancer Care Revenue by Region (2017-2028)
8.3.2 China Genomics In Cancer Care Market Size and Forecast (2017-2028)
8.3.3 Japan Genomics In Cancer Care Market Size and Forecast (2017-2028)
8.3.4 South Korea Genomics In Cancer Care Market Size and Forecast (2017-2028)
8.3.5 India Genomics In Cancer Care Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Genomics In Cancer Care Market Size and Forecast (2017-2028)
8.3.7 Australia Genomics In Cancer Care Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
9.1 South America Genomics In Cancer Care Revenue by Type (2017-2028)
9.2 South America Genomics In Cancer Care Revenue by Application (2017-2028)
9.3 South America Genomics In Cancer Care Market Size by Country
9.3.1 South America Genomics In Cancer Care Revenue by Country (2017-2028)
9.3.2 Brazil Genomics In Cancer Care Market Size and Forecast (2017-2028)
9.3.3 Argentina Genomics In Cancer Care Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Genomics In Cancer Care Revenue by Type (2017-2028)
10.2 Middle East & Africa Genomics In Cancer Care Revenue by Application (2017-2028)
10.3 Middle East & Africa Genomics In Cancer Care Market Size by Country
10.3.1 Middle East & Africa Genomics In Cancer Care Revenue by Country (2017-2028)
10.3.2 Turkey Genomics In Cancer Care Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Genomics In Cancer Care Market Size and Forecast (2017-2028)
10.3.4 UAE Genomics In Cancer Care Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer

List of Tables
Table 1. Global Genomics In Cancer Care Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Genomics In Cancer Care Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Genomics In Cancer Care Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Genomics In Cancer Care Revenue (USD Million) by Region (2017-2022)
Table 5. Global Genomics In Cancer Care Revenue Market Share by Region (2023-2028)
Table 6. Illumina Corporate Information, Head Office, and Major Competitors
Table 7. Illumina Major Business
Table 8. Illumina Genomics In Cancer Care Product and Solutions
Table 9. Illumina Genomics In Cancer Care Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. Thermo Fisher scientific Corporate Information, Head Office, and Major Competitors
Table 11. Thermo Fisher scientific Major Business
Table 12. Thermo Fisher scientific Genomics In Cancer Care Product and Solutions
Table 13. Thermo Fisher scientific Genomics In Cancer Care Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. Agilent Corporate Information, Head Office, and Major Competitors
Table 15. Agilent Major Business
Table 16. Agilent Genomics In Cancer Care Product and Solutions
Table 17. Agilent Genomics In Cancer Care Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. Roche Corporate Information, Head Office, and Major Competitors
Table 19. Roche Major Business
Table 20. Roche Genomics In Cancer Care Product and Solutions
Table 21. Roche Genomics In Cancer Care Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. Cancer Genetics Corporate Information, Head Office, and Major Competitors
Table 23. Cancer Genetics Major Business
Table 24. Cancer Genetics Genomics In Cancer Care Product and Solutions
Table 25. Cancer Genetics Genomics In Cancer Care Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. Beckman Coulter Corporate Information, Head Office, and Major Competitors
Table 27. Beckman Coulter Major Business
Table 28. Beckman Coulter Genomics In Cancer Care Product and Solutions
Table 29. Beckman Coulter Genomics In Cancer Care Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. Bio-Rad Corporate Information, Head Office, and Major Competitors
Table 31. Bio-Rad Major Business
Table 32. Bio-Rad Genomics In Cancer Care Product and Solutions
Table 33. Bio-Rad Genomics In Cancer Care Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. Danaher Corporate Information, Head Office, and Major Competitors
Table 35. Danaher Major Business
Table 36. Danaher Genomics In Cancer Care Product and Solutions
Table 37. Danaher Genomics In Cancer Care Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. Sigma Aldrich Corporate Information, Head Office, and Major Competitors
Table 39. Sigma Aldrich Major Business
Table 40. Sigma Aldrich Genomics In Cancer Care Product and Solutions
Table 41. Sigma Aldrich Genomics In Cancer Care Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. Pacific Biosciences Corporate Information, Head Office, and Major Competitors
Table 43. Pacific Biosciences Major Business
Table 44. Pacific Biosciences Genomics In Cancer Care Product and Solutions
Table 45. Pacific Biosciences Genomics In Cancer Care Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 46. Quest Diagnostics Corporate Information, Head Office, and Major Competitors
Table 47. Quest Diagnostics Major Business
Table 48. Quest Diagnostics Genomics In Cancer Care Product and Solutions
Table 49. Quest Diagnostics Genomics In Cancer Care Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 50. Luminex Corporate Information, Head Office, and Major Competitors
Table 51. Luminex Major Business
Table 52. Luminex Genomics In Cancer Care Product and Solutions
Table 53. Luminex Genomics In Cancer Care Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 54. Oxford Gene Technology Corporate Information, Head Office, and Major Competitors
Table 55. Oxford Gene Technology Major Business
Table 56. Oxford Gene Technology Genomics In Cancer Care Product and Solutions
Table 57. Oxford Gene Technology Genomics In Cancer Care Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 58. PerkinElmer Corporate Information, Head Office, and Major Competitors
Table 59. PerkinElmer Major Business
Table 60. PerkinElmer Genomics In Cancer Care Product and Solutions
Table 61. PerkinElmer Genomics In Cancer Care Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 62. Qiagen Corporate Information, Head Office, and Major Competitors
Table 63. Qiagen Major Business
Table 64. Qiagen Genomics In Cancer Care Product and Solutions
Table 65. Qiagen Genomics In Cancer Care Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 66. GE Healthcare Corporate Information, Head Office, and Major Competitors
Table 67. GE Healthcare Major Business
Table 68. GE Healthcare Genomics In Cancer Care Product and Solutions
Table 69. GE Healthcare Genomics In Cancer Care Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 70. Global Genomics In Cancer Care Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 71. Global Genomics In Cancer Care Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 72. Breakdown of Genomics In Cancer Care by Company Type (Tier 1, Tier 2 and Tier 3)
Table 73. Genomics In Cancer Care Players Head Office, Products and Services Provided
Table 74. Genomics In Cancer Care Mergers & Acquisitions in the Past Five Years
Table 75. Genomics In Cancer Care New Entrants and Expansion Plans
Table 76. Global Genomics In Cancer Care Revenue (USD Million) by Type (2017-2022)
Table 77. Global Genomics In Cancer Care Revenue Share by Type (2017-2022)
Table 78. Global Genomics In Cancer Care Revenue Forecast by Type (2023-2028)
Table 79. Global Genomics In Cancer Care Revenue by Application (2017-2022)
Table 80. Global Genomics In Cancer Care Revenue Forecast by Application (2023-2028)
Table 81. North America Genomics In Cancer Care Revenue by Type (2017-2022) & (USD Million)
Table 82. North America Genomics In Cancer Care Revenue by Type (2023-2028) & (USD Million)
Table 83. North America Genomics In Cancer Care Revenue by Application (2017-2022) & (USD Million)
Table 84. North America Genomics In Cancer Care Revenue by Application (2023-2028) & (USD Million)
Table 85. North America Genomics In Cancer Care Revenue by Country (2017-2022) & (USD Million)
Table 86. North America Genomics In Cancer Care Revenue by Country (2023-2028) & (USD Million)
Table 87. Europe Genomics In Cancer Care Revenue by Type (2017-2022) & (USD Million)
Table 88. Europe Genomics In Cancer Care Revenue by Type (2023-2028) & (USD Million)
Table 89. Europe Genomics In Cancer Care Revenue by Application (2017-2022) & (USD Million)
Table 90. Europe Genomics In Cancer Care Revenue by Application (2023-2028) & (USD Million)
Table 91. Europe Genomics In Cancer Care Revenue by Country (2017-2022) & (USD Million)
Table 92. Europe Genomics In Cancer Care Revenue by Country (2023-2028) & (USD Million)
Table 93. Asia-Pacific Genomics In Cancer Care Revenue by Type (2017-2022) & (USD Million)
Table 94. Asia-Pacific Genomics In Cancer Care Revenue by Type (2023-2028) & (USD Million)
Table 95. Asia-Pacific Genomics In Cancer Care Revenue by Application (2017-2022) & (USD Million)
Table 96. Asia-Pacific Genomics In Cancer Care Revenue by Application (2023-2028) & (USD Million)
Table 97. Asia-Pacific Genomics In Cancer Care Revenue by Region (2017-2022) & (USD Million)
Table 98. Asia-Pacific Genomics In Cancer Care Revenue by Region (2023-2028) & (USD Million)
Table 99. South America Genomics In Cancer Care Revenue by Type (2017-2022) & (USD Million)
Table 100. South America Genomics In Cancer Care Revenue by Type (2023-2028) & (USD Million)
Table 101. South America Genomics In Cancer Care Revenue by Application (2017-2022) & (USD Million)
Table 102. South America Genomics In Cancer Care Revenue by Application (2023-2028) & (USD Million)
Table 103. South America Genomics In Cancer Care Revenue by Country (2017-2022) & (USD Million)
Table 104. South America Genomics In Cancer Care Revenue by Country (2023-2028) & (USD Million)
Table 105. Middle East & Africa Genomics In Cancer Care Revenue by Type (2017-2022) & (USD Million)
Table 106. Middle East & Africa Genomics In Cancer Care Revenue by Type (2023-2028) & (USD Million)
Table 107. Middle East & Africa Genomics In Cancer Care Revenue by Application (2017-2022) & (USD Million)
Table 108. Middle East & Africa Genomics In Cancer Care Revenue by Application (2023-2028) & (USD Million)
Table 109. Middle East & Africa Genomics In Cancer Care Revenue by Country (2017-2022) & (USD Million)
Table 110. Middle East & Africa Genomics In Cancer Care Revenue by Country (2023-2028) & (USD Million)
List of Figures
Figure 1. Genomics In Cancer Care Picture
Figure 2. Global Genomics In Cancer Care Revenue Market Share by Type in 2021
Figure 3. Instruments
Figure 4. Consumables
Figure 5. Services
Figure 6. Genomics In Cancer Care Revenue Market Share by Application in 2021
Figure 7. Diagnostics Picture
Figure 8. Personalized Medicine Picture
Figure 9. Drug Discovery Picture
Figure 10. Development Picture
Figure 11. Research Picture
Figure 12. Global Genomics In Cancer Care Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 13. Global Genomics In Cancer Care Revenue and Forecast (2017-2028) & (USD Million)
Figure 14. Global Genomics In Cancer Care Revenue Market Share by Region (2017-2028)
Figure 15. Global Genomics In Cancer Care Revenue Market Share by Region in 2021
Figure 16. North America Genomics In Cancer Care Revenue (USD Million) and Growth Rate (2017-2028)
Figure 17. Europe Genomics In Cancer Care Revenue (USD Million) and Growth Rate (2017-2028)
Figure 18. Asia-Pacific Genomics In Cancer Care Revenue (USD Million) and Growth Rate (2017-2028)
Figure 19. South America Genomics In Cancer Care Revenue (USD Million) and Growth Rate (2017-2028)
Figure 20. Middle East and Africa Genomics In Cancer Care Revenue (USD Million) and Growth Rate (2017-2028)
Figure 21. Genomics In Cancer Care Market Drivers
Figure 22. Genomics In Cancer Care Market Restraints
Figure 23. Genomics In Cancer Care Market Trends
Figure 24. Illumina Recent Developments and Future Plans
Figure 25. Thermo Fisher scientific Recent Developments and Future Plans
Figure 26. Agilent Recent Developments and Future Plans
Figure 27. Roche Recent Developments and Future Plans
Figure 28. Cancer Genetics Recent Developments and Future Plans
Figure 29. Beckman Coulter Recent Developments and Future Plans
Figure 30. Bio-Rad Recent Developments and Future Plans
Figure 31. Danaher Recent Developments and Future Plans
Figure 32. Sigma Aldrich Recent Developments and Future Plans
Figure 33. Pacific Biosciences Recent Developments and Future Plans
Figure 34. Quest Diagnostics Recent Developments and Future Plans
Figure 35. Luminex Recent Developments and Future Plans
Figure 36. Oxford Gene Technology Recent Developments and Future Plans
Figure 37. PerkinElmer Recent Developments and Future Plans
Figure 38. Qiagen Recent Developments and Future Plans
Figure 39. GE Healthcare Recent Developments and Future Plans
Figure 40. Global Genomics In Cancer Care Revenue Share by Players in 2021
Figure 41. Genomics In Cancer Care Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 42. Global Top 3 Players Genomics In Cancer Care Revenue Market Share in 2021
Figure 43. Global Top 10 Players Genomics In Cancer Care Revenue Market Share in 2021
Figure 44. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 45. Global Genomics In Cancer Care Revenue Share by Type in 2021
Figure 46. Global Genomics In Cancer Care Market Share Forecast by Type (2023-2028)
Figure 47. Global Genomics In Cancer Care Revenue Share by Application in 2021
Figure 48. Global Genomics In Cancer Care Market Share Forecast by Application (2023-2028)
Figure 49. North America Genomics In Cancer Care Sales Market Share by Type (2017-2028)
Figure 50. North America Genomics In Cancer Care Sales Market Share by Application (2017-2028)
Figure 51. North America Genomics In Cancer Care Revenue Market Share by Country (2017-2028)
Figure 52. United States Genomics In Cancer Care Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Canada Genomics In Cancer Care Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Mexico Genomics In Cancer Care Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Europe Genomics In Cancer Care Sales Market Share by Type (2017-2028)
Figure 56. Europe Genomics In Cancer Care Sales Market Share by Application (2017-2028)
Figure 57. Europe Genomics In Cancer Care Revenue Market Share by Country (2017-2028)
Figure 58. Germany Genomics In Cancer Care Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. France Genomics In Cancer Care Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. United Kingdom Genomics In Cancer Care Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Russia Genomics In Cancer Care Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Italy Genomics In Cancer Care Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Asia-Pacific Genomics In Cancer Care Sales Market Share by Type (2017-2028)
Figure 64. Asia-Pacific Genomics In Cancer Care Sales Market Share by Application (2017-2028)
Figure 65. Asia-Pacific Genomics In Cancer Care Revenue Market Share by Region (2017-2028)
Figure 66. China Genomics In Cancer Care Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Japan Genomics In Cancer Care Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. South Korea Genomics In Cancer Care Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. India Genomics In Cancer Care Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Southeast Asia Genomics In Cancer Care Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. Australia Genomics In Cancer Care Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. South America Genomics In Cancer Care Sales Market Share by Type (2017-2028)
Figure 73. South America Genomics In Cancer Care Sales Market Share by Application (2017-2028)
Figure 74. South America Genomics In Cancer Care Revenue Market Share by Country (2017-2028)
Figure 75. Brazil Genomics In Cancer Care Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Argentina Genomics In Cancer Care Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Middle East and Africa Genomics In Cancer Care Sales Market Share by Type (2017-2028)
Figure 78. Middle East and Africa Genomics In Cancer Care Sales Market Share by Application (2017-2028)
Figure 79. Middle East and Africa Genomics In Cancer Care Revenue Market Share by Country (2017-2028)
Figure 80. Turkey Genomics In Cancer Care Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 81. Saudi Arabia Genomics In Cancer Care Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 82. UAE Genomics In Cancer Care Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 83. Methodology
Figure 84. Research Process and Data Source

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Agrigenomics Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 87

Agrigenomics is product and scientific services in genomics field for agriculture and livestock. Include DNA extraction and purification, DNA/RNA sequencing, Genotyping, Gene expression profiling, Marker-assisted selection, GMO/Trait purity and other technology. The global Agrigenomics market was valued at US$ 4849.2 million in 2023 and is anticipated to reach US$ 7524.5 million by 2030, witnessing a CAGR of 6.4% during The forecast period 2024-2030. Thermo Fisher Scientific,......

Global Agrigenomics Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 108

According to our LPI (LP Information) latest study, the global Agrigenomics market size was valued at US$ 4743.7 million in 2023. With growing demand in downstream market, the Agrigenomics is forecast to a readjusted size of US$ 7439.4 million by 2030 with a CAGR of 6.6% during review period. The research report highlights the growth potential of the global Agrigenomics market. Agrigenomics are expected to show stable growth in the future market. However, product differentiation, reducin......

Global Agrigenomics Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 108

According to our (Global Info Research) latest study, the global Agrigenomics market size was valued at USD 4989.6 million in 2023 and is forecast to a readjusted size of USD 7564.5 million by 2030 with a CAGR of 6.1% during review period. Agrigenomics is product and scientific services in genomics field for agriculture and livestock. Include DNA extraction and purification, DNA/RNA sequencing, Genotyping, Gene expression profiling, Marker-assisted selection, GMO/Trait purity and other t......

Global Gene Editing Market Research Report 2023

Published: 14-Dec-2023        Price: US 2900 Onwards        Pages: 97

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Gene Editing market with multiple angles, which provides sufficient supports to readers' strategy and decision making. By Company - Thermo Fisher Scientific - Merck - Horizo??n Discovery - Sangamo BioSciences - Integrated DNA Technologies - Lonza - New England Biolabs - ......

Global Agrigenomics Professional Survey Report 2023, Forecast to 2028

Published: 21-Nov-2023        Price: US 3280 Onwards        Pages: 101

Agricultural genomics (AgriGenomics) is the application of genomics in agriculture to improve the productivity and sustainability in crop and livestock production. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Te......

Global Agrigenomics Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 21-Nov-2023        Price: US 3380 Onwards        Pages: 99

Market Overview of Global Agrigenomics market: According to our latest research, the global Agrigenomics market looks promising in the next 5 years. As of 2022, the global Agrigenomics market was estimated at USD 5139.47 million, and it's anticipated to reach USD 7676.54 million in 2028, with a CAGR of 6.92% during the forecast years. Agrigenomics is defined as the study of the genetic makeup of crops and livestock and how genes influence the produce. Application of genomics ......

Global Agrigenomics Market Research Report 2023, Forecast to 2028

Published: 21-Nov-2023        Price: US 2680 Onwards        Pages: 166

Agricultural genomics (AgriGenomics) is the application of genomics in agriculture to improve the productivity and sustainability in crop and livestock production. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Te......

Global Genomics in Cancer Care Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 02-Nov-2023        Price: US 3380 Onwards        Pages: 101

Market Overview of Global Genomics in Cancer Care market: According to our latest research, the global Genomics in Cancer Care market looks promising in the next 5 years. As of 2022, the global Genomics in Cancer Care market was estimated at USD 4369.0 million, and it's anticipated to reach USD 11429.15 million in 2028, with a CAGR of 17.38% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of ......

Gene Editing Collaboration and Licensing Deals 2016-2023

Published: 01-Nov-2023        Price: US 3995 Onwards        Pages: 200

Gene Editing Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the gene editing deals entered into by the worlds leading biopharma companies. Fully revised and updated, the report provides details of gene editing deals from 2016 to 2023. The report provides a detailed understanding and analysis of how and why companies enter gene editing deals. These deals tend to be multicomponent, starting with collaborative R&D, and ......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs